Literature DB >> 26897699

Evaluation of the effectiveness of manual and automated dialyzers reprocessing after multiple reuses.

Alexandra do Rosário Toniolo1, Maíra Marques Ribeiro2, Marina Ishii3, Cely Barreto da Silva4, Lycia Mara Jenné Mimica5, Kazuko Uchikawa Graziano6.   

Abstract

A cross-sectional study was conducted to evaluate the effectiveness of manual and automated dialyzer reprocessing. Dialyzers were filled with fluid thioglycollate medium from blood and dialysate chambers after being reprocessed and chemically sterilized with 0.2% peracetic acid. They were incubated for 14 days at 35°C ± 2°C, and microbiologic analysis was performed. Microorganisms were identified in 3 of the 11 samples (27.3%) from the blood chambers: Sphingomonas paucimobilis (2/3) and Penicillium spp (1/3) and in 11 of the 11 samples (100%) from the dialysate chambers: S paucimobilis (7/11), Stenotrophomonas maltophilia (4/11), Pseudomonas aeruginosa (3/11), Candida spp (1/11), and Acinetobacter baumannii (1/11). Of the 4 manually reprocessed dialyzers, gram-positive bacillus were identified in 1 sample (25%) from the blood chamber, and Bacillus spp and Burkholderia spp were identified in 1 sample (25%) from the dialysate chamber. The dialyzers reprocessing can pose risks safety because of exposure patient to microorganisms.
Copyright © 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hemodialyzer; reuse; sterilization

Mesh:

Substances:

Year:  2016        PMID: 26897699     DOI: 10.1016/j.ajic.2015.12.035

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  1 in total

1.  Hemodialyzer Reuse and Gram-Negative Bloodstream Infections.

Authors:  Chris Edens; Jacklyn Wong; Meghan Lyman; Kyle Rizzo; Duc Nguyen; Michela Blain; Sam Horwich-Scholefield; Heather Moulton-Meissner; Erin Epson; Jon Rosenberg; Priti R Patel
Journal:  Am J Kidney Dis       Date:  2016-12-07       Impact factor: 8.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.